Innovation to Protect (I2P) Scheme
Funding the patent expenses of a validated innovation
This scheme funds expenses to protect patentable innovations with significant healthcare impact and commercial potential.
Funding for both solely owned and jointly owned innovations is considered if the application satisfies the following criteria:
- Strong patent position in terms of novelty and inventiveness
- A work plan detailing further development of the innovation with milestones and endpoints
- Commercial plan outlining proposed route to market, healthcare impact, competing technologies and potential industry partners
The I2P funding support is applicable for the following patenting stages: First Filing, PCT filing and prosecution, National Phase Entry and prosecution, Grant and Maintenance.
Funding for protection of intellectual property
Funding quantum for eligible applications varies depending on the stage of patenting and ownership of the innovation.
|Stage||Stage Description||Grant Duration (Letter of Award)||Grant Quantum (when host institution owns >50% of IP)||Grant Quantum (when host institution owns <= 50% of IP)|
|1||First Filing||6 months||$10,000||$5,000|
|4||National Phase||12 months||$40,000 for 2 territories||$20,000 for 2 territories|
|6||Grant & Maintenance||6 months||$20,000||$10,000|
Please refer to NHIC I2P Grant Application Form for further details on funding quantum and duration.
One of the inventors must hold a primary appointment in a public hospital/public health institution/national speciality centre in Singapore and be salaried by the institution. Project teams must contain strong clinical representation. All applications are subject to a due diligence process by NHIC prior to awarding funding.
For any queries concerning eligibility, please contact the NHIC I2P Grant Secretariat at firstname.lastname@example.org.
Terms and Conditions
For the Terms and Conditions governing NHIC grants, please see Terms and Conditions.
This scheme has a rolling application process i.e. applications can be submitted to NHIC at any time.
Eligible applications for this scheme should submit the NHIC I2P Grant Application Form along with either their institutions Invention Disclosure Form or NHIC’s Invention Disclosure Form and other supporting documents to NHIC Grant Secretariat at email@example.com. Only applications endorsed and submitted by the Research/Innovation Office of your Healthcare Cluster are accepted by NHIC.
For further information on our process, please see How we work.